ScopeUniversitätsklinikum Frankfurt Zentrum der Inneren Medizin, Medizinische Klinik 2 Hämatologisch-Onkologisches Speziallabor
42 capabilities
Accredited since June 2025
Verified May 2026
One of 3,188 in Germany
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
Theodor-Stern-Kai 7
Frankfurt am Main 60590 , Germany
Frankfurt am Main 60590 , Germany
Accreditation
Active
DAkkS
D-ML-13102-06-00
Specialises in haematology-oncology laboratory diagnostics, including flow cytometry analysis of bone marrow and peripheral blood samples for clinical chemistry and molecular genetic investigations.
Accreditation Details
Accreditation Body
DAkkS
Number
D-ML-13102-06-00
Status
ActiveSince
25 June 2025
Accreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official DAkkS records.
Download Scope PDF
Test Capabilities (42)
| Standard Reference | Description | Category |
|---|---|---|
| Zellzahlbestimmung | Zellzahlbestimmung | Clinical Chemistry |
| (ATM, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, NBN, PALB2, RAD51C, RAD51D, TP53) | (ATM, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, NBN, PALB2, RAD51C, RAD51D, TP53) | Elemental Analysis |
| (BRCA2) | (BRCA2) | Elemental Analysis |
| CEBPA | exon11, FLT3-ITD, CEBPA | Elemental Analysis |
| IDH1 exon 4, IDH2 exon | IDH1 exon 4, IDH2 exon | Elemental Analysis |
| Mutation bei der AML (IDH1) | Mutation bei der AML (IDH1) | Elemental Analysis |
| RUNX1, SETBP1, SF3B1, TET2, TP53, U2AF1) | RUNX1, SETBP1, SF3B1, TET2, TP53, U2AF1) | Elemental Analysis |
| SETBP1, SF3B1, SRSF2, TET2, U2AF1) | SETBP1, SF3B1, SRSF2, TET2, U2AF1) | Elemental Analysis |
| Zell-Differenzierung von | Zell-Differenzierung von | Food Safety Testing |
| Akuten Leukämien | Akuten Leukämien | Hematology |
| Blutbild | manuelles Differentialblutbild | Hematology |
| Charakterisierung von akuten | Charakterisierung von akuten | Hematology |
| Ergußpräparaten (Zytospin) | Ergußpräparaten (Zytospin) | Histopathology / Cytology |
| Knochenmark | Knochenmark | Histopathology / Cytology |
| Zell-Differentierung von | Zell-Differentierung von | Histopathology / Cytology |
| (ABL1) | Leukämie (ABL1) | Molecular Diagnostics / PCR |
| (BRCA1 P002) | (BRCA1 P002) | Molecular Diagnostics / PCR |
| (BRCA1) | (BRCA1) | Molecular Diagnostics / PCR |
| (BRCA2/CHEK2 P045-B3) | (BRCA2/CHEK2 P045-B3) | Molecular Diagnostics / PCR |
| (FLT3-ITD) | Mutation bei der AML (FLT3-ITD) | Molecular Diagnostics / PCR |
| (FLT3-TKD) | Mutation bei der AML (FLT3-TKD) | Molecular Diagnostics / PCR |
| (NPM1) | Mutation bei der AML (NPM1) | Molecular Diagnostics / PCR |
| Brust- und Eierstockkrebs | Familiärer Brust- und Eierstockkrebs | Molecular Diagnostics / PCR |
| Leukämie (GUS) | Leukämie (GUS) | Molecular Diagnostics / PCR |
| Mutation bei der AML (NPM1-A) | Mutation bei der AML (NPM1-A) | Molecular Diagnostics / PCR |
| Mutation bei der AML (NPM1-B) | Mutation bei der AML (NPM1-B) | Molecular Diagnostics / PCR |
| Mutation bei der AML (NPM1-D) | Mutation bei der AML (NPM1-D) | Molecular Diagnostics / PCR |
| chromosomale Aberrationen | chromosomale Aberrationen | Molecular Diagnostics / PCR |
| AF9, MLL-ELL, MLL-PTD, MLF1, PML-RARA) | AF9, MLL-ELL, MLL-PTD, MLF1, PML-RARA) | Other |
| AML (Detektion der Fusionsgene | AML (Detektion der Fusionsgene | Other |
| B-Zellzahl (Immunstatus | B-Zellzahl (Immunstatus | Other |
| ETO(RUNX1-RUNX1T1)) | ETO(RUNX1-RUNX1T1)) | Other |
| Leukämien (Fusionsgen | Leukämien (Fusionsgen | Other |
| Leukämien (Minor - und | Leukämien (Minor - und | Other |
| MYH11) | MYH11) | Other |
| MYH11-A) | MYH11-A) | Other |
| MYH11-D) | MYH11-D) | Other |
| MYH11-E) | MYH11-E) | Other |
| Mutation bei MPN (JAK2 | Mutation bei MPN (JAK2 | Other |
| bcr1) | bcr1) | Other |
| bcr2) | bcr2) | Other |
| bcr3) | bcr3) | Other |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.